These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 35008927)

  • 1. Stem Cell-Derived β Cells: A Versatile Research Platform to Interrogate the Genetic Basis of β Cell Dysfunction.
    Bartolomé A
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers.
    George MN; Leavens KF; Gadue P
    Front Endocrinol (Lausanne); 2021; 12():682625. PubMed ID: 34149620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances and potential applications of human pluripotent stem cell-derived pancreatic β cells.
    Zhou Z; Ma X; Zhu S
    Acta Biochim Biophys Sin (Shanghai); 2020 Jul; 52(7):708-715. PubMed ID: 32445468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Genetic Association to Molecular Mechanisms for Islet-cell Dysfunction in Type 2 Diabetes.
    Mattis KK; Gloyn AL
    J Mol Biol; 2020 Mar; 432(5):1551-1578. PubMed ID: 31945378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing of human pancreatic beta cell models: problems, possibilities and outlook.
    Balboa D; Prasad RB; Groop L; Otonkoski T
    Diabetologia; 2019 Aug; 62(8):1329-1336. PubMed ID: 31161346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling different types of diabetes using human pluripotent stem cells.
    Abdelalim EM
    Cell Mol Life Sci; 2021 Mar; 78(6):2459-2483. PubMed ID: 33242105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
    Liew CG
    Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells.
    Cnop M; Toivonen S; Igoillo-Esteve M; Salpea P
    Mol Metab; 2017 Sep; 6(9):1024-1039. PubMed ID: 28951826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pancreatic β cell: recent insights from human genetics.
    Thomsen SK; Gloyn AL
    Trends Endocrinol Metab; 2014 Aug; 25(8):425-34. PubMed ID: 24986330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human pluripotent stem cell based islet models for diabetes research.
    Balboa D; Otonkoski T
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Pluripotent Stem Cells to Model Islet Defects in Diabetes.
    Balboa D; Iworima DG; Kieffer TJ
    Front Endocrinol (Lausanne); 2021; 12():642152. PubMed ID: 33828531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
    Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H
    Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants.
    Heller S; Melzer MK; Azoitei N; Julier C; Kleger A
    Front Endocrinol (Lausanne); 2021; 12():648284. PubMed ID: 34079523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monogenic Diabetes Modeling:
    Burgos JI; Vallier L; Rodríguez-Seguí SA
    Front Endocrinol (Lausanne); 2021; 12():692596. PubMed ID: 34295307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy.
    Wang X; Gao M; Wang Y; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():927324. PubMed ID: 35966093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.
    Sackett SD; Rodriguez A; Odorico JS
    Rev Diabet Stud; 2017; 14(1):39-50. PubMed ID: 28632820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes.
    Pellegrini S; Zamarian V; Sordi V
    Transpl Int; 2022; 35():10575. PubMed ID: 36090777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics.
    Krentz NAJ; Gloyn AL
    Nat Rev Endocrinol; 2020 Apr; 16(4):202-212. PubMed ID: 32099086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise Review: Human Pluripotent Stem Cells for the Modeling of Pancreatic β-Cell Pathology.
    Balboa D; Saarimäki-Vire J; Otonkoski T
    Stem Cells; 2019 Jan; 37(1):33-41. PubMed ID: 30270471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent stem cell-derived pancreatic β-cells: potential for regenerative medicine in diabetes.
    Kao DI; Chen S
    Regen Med; 2012 Jul; 7(4):583-93. PubMed ID: 22817630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.